Month: February 2024

Board of Directors Declared Total Dividends of $0.65 per Share for First Quarter 2024Base Dividend of $0.43 and Supplemental Dividend...

EMERYVILLE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic...

Q4 Revenue of $21.8 million, up 4% year-over-year Q4 Ending ARR1 of $75.0 million, up 120% year-over-year Q4 Ending RPO2...

– Plan to initiate the Phase 3 ENLIGHTEN NASH program for non-cirrhotic (F2-F3) and cirrhotic (F4) patients in the first...

COLUMBUS, Ohio, Feb. 29, 2024 /PRNewswire/ -- Diamond Hill Investment Group, Inc. (Nasdaq: DHIL) today reported results for the fourth...

SAN MATEO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to...

- First patient dosed in Phase 2 first-line trial in patients with RAS-mutated mCRC for new lead program with the...

Contacts Tracey Schroeder Chief Marketing Officer Tracey.schroeder@cpsi.com (251) 639-8100 CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced results for...

SALT LAKE CITY, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company...

NATICK, Mass., Feb. 29, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX) today announced that Rob Willett, President and Chief Executive...

PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its...

ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced...

-Enrollment Complete in Cohort A of Phase 3, Pivotal, HOPE-3 Trial of CAP-1002 in Duchenne Muscular Dystrophy; Announced Successful Interim Futility...

GUADALAJARA, Mexico, Feb. 29, 2024 /PRNewswire/ -- Betterware de México, S.A.P.I. de C.V. (NASDAQ: BWMX), ("BeFra" or the 'Company'"), the leading...

Company Achieves Second Highest Fiscal Year Revenue in Company History Despite Restricted Supply of Smoothie Bottle Product Throughout Fiscal Year...

Fourth quarter Cell Processing revenue up 11% sequentially to $14.8 million, and positive adjusted EBITDA of $700,000 Expects 2024 revenue...

Full year SaaS revenue of $161.0 million, representing 37% year-over-year growthFull year Total revenue of $271.8 million, representing 17% year-over-year...

LAKE FOREST, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty...

Fiscal Third Quarter 2024 Financial Highlights: Net sales decreased 12.2% year-over-year to $422.1 million Net income increased 44.1% year-over-year to...

Alvotech (NASDAQ: ALVO) tilkynnti í dag að Christina Siniscalchi hafi verið skipuð tímabundið í stöðu framkvæmdastjóra gæðamála. Christina tekur við...

- Fourth quarter revenue grew 11 percent, and 14 percent at constant exchange rates, to $1.5 billion - Fourth quarter...

Company to Host Quarterly Conference Call at 5:00 P.M. ET on February 29, 2024 The information in this press release...

FY 2023 Revenue Increased 17% to $184.3 Million Company Announces Additional $20 Million Stock Repurchase Plan ENGLEWOOD, Colo., Feb. 29,...

LYNNWOOD, Wash., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) today announced it will report fiscal 2023 fourth...

Second Quarter HighlightsSAN JOSE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today...

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...

XEN1101 Phase 3 epilepsy program continues to progress with X-TOLE2 and X-TOLE3 in focal onset seizures and X-ACKT in primary...

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verita (Verita CSG, Inc.), a visionary Managing General Underwriting (MGU) company, announced...

MESA, Ariz., Feb. 29, 2024 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announced...

Poster highlights clinical overlap of ALSP and multiple sclerosis (MS) and details patients’ barriers to genetic testingWATERTOWN, Mass., Feb. 29, 2024...

Contacts Kiley Rawlins, CFA Vice President, Investor Relations krawlins@ulta.com Crystal Carroll Senior Director, Public Relations Ccarroll@ulta.com Ulta Beauty, Inc. (NASDAQ:...

Contacts Investor Relations Contact: Drew Mackintosh drew@mackintoshir.com Mobile: 310-924-9036 United Homes Group (NASDAQ: UHG) announced today that the company will...

Full Year 2023Revenue was $2.463 Billion, up 0.8 PercentOperating Income was $118.0 Million or 4.8 Percent of Revenue($200.4 Million or...

DALLAS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (the “Company”) (Nasdaq: TFIN) today announced that the Company’s Board...

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine (AZA) in...

MINNEAPOLIS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail cloud services, today announced...

Combined Cumulative Subscriptions & Bookings Backlog of $661 Million Represents a 2x increase Year-Over-Year Contacts Investors: Scott Smith 408-724-1498 IR@SoundHound.com...

PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic...